Prot# NU MSK02H1: Phase II Trial of Oral Bexarotene (Targretin®) Combined with Interferon Alfa-2b (Intron-A®) for Patients with Cutaneous T-Cell Lymphoma (Sloan IRB# 01-128A(3))

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/20/021/1/11

Funding

  • Memorial Sloan Kettering Cancer Center (NU MSK02H1 // NU MSK02H1)
  • Ligand Pharmaceuticals, Inc. (NU MSK02H1 // NU MSK02H1)